Digital Pathology Market - Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/ Cloud Based) and Whole Slide Image Storage - Global Trends & Forecast till 2017
Upcoming SlideShare
Loading in...5
×
 

Digital Pathology Market - Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/ Cloud Based) and Whole Slide Image Storage - Global Trends & Forecast till 2017

on

  • 426 views

 

Statistics

Views

Total Views
426
Views on SlideShare
426
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Adobe PDF

Usage Rights

© All Rights Reserved

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment

Digital Pathology Market - Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/ Cloud Based) and Whole Slide Image Storage - Global Trends & Forecast till 2017 Digital Pathology Market - Slide Scanners (Whole Slide Imaging), Analytics (Image Analysis Software), Delivery Modes (Web Based/ Cloud Based) and Whole Slide Image Storage - Global Trends & Forecast till 2017 Document Transcript

  • Digital Pathology Market - Slide Scanners (Whole SlideImaging), Analytics (Image Analysis Software), Delivery Modes(Web Based/ Cloud Based) and Whole Slide Image Storage -Global Trends & Forecast till 2017Report Details:Published:October 2012No. of Pages: 233Price: Single User License – US$4650The life science industry is now witnessing the second decade of “Biologic Revolution”. Theadoption and up gradation of technology is increasing rapidly. Conventional practices are beingreplaced by advanced technologies. The perception of pathological laboratories needs to beimproved as the consumer expectations and government regulations towards improved patientsafety, accurate diagnosis, Electronic Medical Records (EMR) as well as personalized medicinesare growing. Pathology plays a significant role in patient care. Digital pathology serves thispurpose by providing a facility for digital transformation of pathology and laboratory medicine.Digital pathology is currently gaining momentum as pathologists are seeking to achieve workflowefficiency and cost cutting in the pathological process. It provides ready access to premium qualityslide images, enabling better and fast diagnosis, as well as preservation of these digital slides forfuture reference. The digital pathology market is driven by the factors such as reduction inlaboratory expenses, improvement in operational efficiency, and treatment decisions and patientcare. The rising prevalence of cancer, increasing trends in drug development, companiondiagnostics, and ease of consultation are the major drivers that are slated to propel this market.However, a few pivotal factors restraining the growth of this market are FDA regulations in someregions, high cost of Digital Pathology Systems (DPS), technological problems, and conservativeoutlook of pathologists. There are a few well-established firms and several small ones operating inthis industry. The major players in the market are Aperio Technologies, Inc. (U.S.), VentanaMedical Systems (U.S.), Leica Microsystems GmbH (Germany), Digipath (U.S.), and HamamatsuPhotonics (Japan).The global digital pathology market is broadly segmented into two categories based on itsproducts and application. The product category includes scanners, analytics (visualizationsoftware, information management systems and image analysis platforms), storage andcommunication (sharing services, software), while the application category comprises humanpathology and animal pathology. Both these markets are dominated by North America in 2012,followed by Europe, Asia, and Rest of the World (RoW). The global digital pathology market is
  • estimated to be $191.00 million in 2012, and is poised to grow at a CAGR of 12% to reach$336.61 million by 2017.The global digital pathology market is dominated by the North America, followed by Europe, Asia,and Rest of the World. North America will continue to lead the digital pathology market for the nextfive years in spite of stringent FDA regulations and premarketing approvals. This is due to theincreasing adoption of digital pathology systems by research labs, pharmaceutical andbiotechnology companies, clinical research institutes, contract research organizations, etc.Moreover, the capacity to spend money is also driving the growth in this geography. However, arobust growth rate will be observed in Europe as vendors and manufacturers will be seen turningtowards the region for regulatory reliefs. The Asian region’s contribution to the global digitalpathology market is also expected to pick up in the coming years, as the technology gets morerecognition and becomes more cost effective.Scope of the ReportThis research report categorizes the global digital pathology market into different segments basedon its products and application.Global digital pathology market, by products•Scanners•Analytics•Storage•CommunicationGlobal digital pathology market, by applicationHuman Pathology•Pharmaceutical and Biotechnology companies•Clinical Research•EducationAnimal Pathology•Pharmaceutical and Biotechnology companies•Academic and Government Research•Contract Research OrganizationsDigital pathology market, by geographyNorth America•U.S.•CanadaEurope•U.K.•Germany•Italy•France•Spain•Denmark•Norway
  • •Sweden•Rest of EuropeAsia•China•Japan•India•Rest of AsiaRest of the World (RoW)•Latin America•Africa•Russia•Middle East•Pacific CountriesGet your copy of this report @http://www.reportsnreports.com/reports/195916-digital-pathology-market-slide-scanners-whole-slide-imaging-analytics-image-analysis-software-delivery-modes-web-based-cloud-based-and-whole-slide-image-storage-global-trends-forecast-till-2017.htmlMajor points covered in Table of Contents of this report includeTABLE OF CONTENTS1 INTRODUCTION1.1 KEY TAKE-AWAYS1.2 REPORT DESCRIPTION1.3 MARKETS COVERED1.4 STAKEHOLDERS1.5 RESEARCH METHODOLOGY1.5.1 MARKET SIZE1.5.2 MARKET SHARE1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES2 EXECUTIVE SUMMARY3 MARKET OVERVIEW3.1 INTRODUCTION3.2 EVOLUTION3.3 MARKET SEGMENTATION3.3.1 INTRODUCTION3.4 MARKET DYNAMICS3.4.1 DRIVERS3.4.1.1 Rising Prevalence of Cancer3.4.1.2 Improvement in Lab Efficiency3.4.1.3 Drug Development3.4.1.4 Companion Diagnostics3.4.1.5 Ease of Consultation
  • 3.4.2 RESTRAINTS3.4.2.1 High Cost of Digital Pathology Systems3.4.2.2 Regulatory Concerns3.4.2.3 Technological Problems3.4.2.4 Conservative Outlook of Pathologists3.4.3 OPPORTUNITIES3.4.3.1 Affordable Scanners for Private Pathological Practitioners3.4.3.2 Biopharmaceuticals and Drug Toxicology Studies3.4.3.3 Personalized Medicine3.4.3.4 Workflow Organization in Pathological Labs3.5 MARKET SHARE ANALYSIS, BY KEY PLAYERS4 DIGITAL PATHOLOGY: RATIONALE FOR ADOPTION4.1 INTRODUCTION4.2 ADVANTAGES OF DIGITAL PATHOLOGY4.2.1 GEOGRAPHIC DISTRIBUTION OF PATHOLOGISTS4.2.2 CASE TRANSPORT4.2.3 CASE REVIEW4.2.4 ADDITIONAL STUDIES4.2.5 DIAGNOSIS ENTRY4.2.6 QUALITY CONTROL4.3 WHY A LAB SHOULD ADOPT DIGITAL PATHOLOGY TECHNOLOGY5 GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCTS5.1 INTRODUCTION5.2 SCANNERS5.3 ANALYTICS5.3.1 VISUALIZATION SOFTWARE5.3.2 DIGITAL PATHOLOGY INFORMATION MANAGEMENT SYSTEM5.3.3 IMAGE ANALYSIS PLATFORMS5.4 STORAGE5.5 COMMUNICATION6 GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATION6.1 INTRODUCTION6.2 HUMAN PATHOLOGY6.2.1 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES6.2.2 CLINICAL RESEARCH6.2.3 EDUCATION6.3 ANIMAL PATHOLOGY6.3.1 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES6.3.2 ACADEMIC & GOVERNMENT RESEARCH6.3.3 CONTRACT RESEARCH ORGANIZATIONS7 GEOGRAPHIC ANALYSIS7.1 INTRODUCTION
  • 7.2 NORTH AMERICA7.2.1 U.S.7.2.2 CANADA7.3 EUROPE7.3.1 U.K.7.3.2 GERMANY7.3.3 ITALY7.3.4 FRANCE7.3.5 SPAIN7.3.6 DENMARK7.3.7 NORWAY7.3.8 SWEDEN7.3.9 REST OF EUROPE7.4 ASIA7.4.1 CHINA7.4.2 JAPAN7.4.3 INDIA7.4.4 REST OF ASIA7.5 ROW (REST OF THE WORLD)7.5.1 LATIN AMERICA7.5.2 AFRICA7.5.3 RUSSIA7.5.4 MIDDLE EAST7.5.5 PACIFIC COUNTRIES8 COMPETITIVE LANDSCAPE8.1 INTRODUCTION8.2 MERGERS & ACQUISITIONS8.3 AGREEMENTS/PARTNERSHIPS/COLLABORATIONS/ JOINT VENTURES8.4 NEW PRODUCT LAUNCH8.5 OTHER DEVELOPMENTS9 COMPANY PROFILES9.1 3DHISTECH, LTD9.1.1 OVERVIEW9.1.2 FINANCIALS9.1.3 PRODUCTS & SERVICES9.1.4 STRATEGY9.1.5 DEVELOPMENTS9.2 APERIO TECHNOLOGIES, INC.9.2.1 OVERVIEW9.2.2 FINANCIALS9.2.3 PRODUCTS & SERVICES9.2.4 STRATEGY
  • 9.2.5 DEVELOPMENTS9.3 APOLLO PACS, INC.9.3.1 OVERVIEW9.3.2 FINANCIALS9.3.3 PRODUCTS & SERVICES9.3.4 STRATEGY9.3.5 DEVELOPMENTS9.4 AURORA INTERACTIVE, LTD.9.4.1 OVERVIEW9.4.2 FINANCIALS9.4.3 PRODUCTS & SERVICES9.4.4 STRATEGY9.4.5 DEVELOPMENTS9.5 CORISTA, LLC9.5.1 OVERVIEW9.5.2 FINANCIALS9.5.3 PRODUCTS & SERVICES9.5.4 STRATEGY9.5.5 DEVELOPMENTS9.6 DEFINIENS AG9.6.1 OVERVIEW9.6.2 FINANCIALS9.6.3 PRODUCTS & SERVICES9.6.4 STRATEGY9.6.5 DEVELOPMENTS9.7 DIGIPATH, INC.9.7.1 OVERVIEW9.7.2 FINANCIALS9.7.3 PRODUCTS & SERVICES9.7.4 STRATEGY9.7.5 DEVELOPMENTS9.8 HAMAMATSU PHOTONICS K.K.9.8.1 OVERVIEW9.8.2 FINANCIALS9.8.3 PRODUCTS & SERVICES9.8.4 STRATEGY9.8.5 DEVELOPMENTS9.9 HURON TECHNOLOGIES INTERNATIONAL, INC.9.9.1 OVERVIEW9.9.2 FINANCIALS9.9.3 PRODUCTS & SERVICES9.9.4 STRATEGY
  • 9.9.5 DEVELOPMENTS9.10 INDICA LABS, INC.9.10.1 OVERVIEW9.10.2 FINANCIALS9.10.3 PRODUCTS & SERVICES9.10.4 STRATEGY9.10.5 DEVELOPMENTS9.11 LEICA MICROSYSTEMS GMBH9.11.1 OVERVIEW9.11.2 FINANCIALS9.11.3 PRODUCTS & SERVICES9.11.4 STRATEGY9.11.5 DEVELOPMENTS9.12 LIGOLAB, LLC9.12.1 OVERVIEW9.12.2 FINANCIALS9.12.3 PRODUCTS & SERVICES9.12.4 STRATEGY9.12.5 DEVELOPMENTS9.13 MIKROSCAN TECHNOLOGIES, INC.9.13.1 OVERVIEW9.13.2 FINANCIALS9.13.3 PRODUCTS & SERVICES9.13.4 STRATEGY9.13.5 DEVELOPMENTS9.14 NIKON INSTRUMENTS, INC.9.14.1 OVERVIEW9.14.2 FINANCIALS9.14.3 PRODUCTS & SERVICES9.14.4 STRATEGY9.14.5 DEVELOPMENTS9.15 OMNYX9.15.1 OVERVIEW9.15.2 FINANCIALS9.15.3 PRODUCTS & SERVICES9.15.4 STRATEGY9.15.5 DEVELOPMENTS9.16 PATHCENTRAL, INC.9.16.1 OVERVIEW9.16.2 FINANCIALS9.16.3 PRODUCTS & SERVICES9.16.4 STRATEGY
  • 9.16.5 DEVELOPMENTS9.17 PATHXL9.17.1 OVERVIEW9.17.2 FINANCIALS9.17.3 PRODUCTS & SERVICES9.17.4 STRATEGY9.17.5 DEVELOPMENTS9.18 PIXCELLDATA, LTD.9.18.1 OVERVIEW9.18.2 FINANCIALS9.18.3 PRODUCTS & SERVICES9.18.4 STRATEGY9.18.5 DEVELOPMENTS9.19 SUNQUEST9.19.1 OVERVIEW9.19.2 FINANCIALS9.19.3 PRODUCTS & SERVICES9.19.4 STRATEGY9.19.5 DEVELOPMENTS9.20 VENTANA MEDICAL SYSTEMS, INC.9.20.1 OVERVIEW9.20.2 FINANCIALS9.20.3 PRODUCTS & SERVICES9.20.4 STRATEGY9.20.5 DEVELOPMENTS9.21 VISIOPHARM9.21.1 OVERVIEW9.21.2 FINANCIALS9.21.3 PRODUCTS & SERVICES9.21.4 STRATEGY9.21.5 DEVELOPMENTSLIST OF TABLESTABLE 1 TYPICAL LABORATORY WORKFLOW STEPS WITH INTEGRATED DIGITALIMAGINGTABLE 2 GLOBAL DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 3 SCANNERS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 4 ANALYTICS MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 5 STORAGE MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 6 COMMUNICATION MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 7 GLOBAL DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)
  • TABLE 8 GLOBAL HUMAN PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 9 HUMAN PATHOLOGY MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 10 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES MARKET REVENUE, BYGEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 11 CLINICAL RESEARCH MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 12 EDUCATION MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 13 GLOBAL ANIMAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 14 ANIMAL PATHOLOGY MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 15 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET REVENUE, BYGEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 16 ACADEMIC AND GOVERNMENT RESEARCH MARKET REVENUE, BYGEOGRAPHY, 2010 – 2017 ($MILLION)TABLE 17 CONTRACT RESEARCH ORGANIZATIONS MARKET REVENUE, BY GEOGRAPHY,2010 – 2017 ($MILLION)TABLE 18 DIGITAL PATHOLOGY MARKET REVENUE, BY GEOGRAPHY, 2010 – 2017($MILLION)TABLE 19 NORTH AMERICA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 20 NORTH AMERICA: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION,2010 – 2017 ($MILLION)TABLE 21 NORTH AMERICA: DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY,2010 – 2017 ($MILLION)TABLE 22 U.S.: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 23 U.S.: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 24 CANADA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 25 CANADA: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 26 EUROPE: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 27 EUROPE: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 28 EUROPE: DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY, 2010 – 2017($MILLION)TABLE 29 U.K.: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017
  • ($MILLION)TABLE 30 U.K.: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 31 GERMANY: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 32 GERMANY: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 33 ITALY: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 34 ITALY: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 35 FRANCE: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 36 FRANCE: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 37 SPAIN: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 38 SPAIN: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 39 DENMARK: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 40 DENMARK: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 41 NORWAY: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 42 NORWAY: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 43 SWEDEN: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 44 SWEDEN: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 45 REST OF EUROPE: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS,2010 – 2017 ($MILLION)TABLE 46 REST OF EUROPE: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION,2010 – 2017 ($MILLION)TABLE 47 ASIA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 48 ASIA : DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 49 ASIA : DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRIES, 2010 – 2017($MILLION)TABLE 50 CHINA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017
  • ($MILLION)TABLE 51 CHINA : DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 52 JAPAN : DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 53 JAPAN: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 54 INDIA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 55 INDIA : DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 56 REST OF ASIA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010– 2017 ($MILLION)TABLE 57 REST OF ASIA: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION,2010 – 2017 ($MILLION)TABLE 58 ROW: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 59 ROW: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 – 2017($MILLION)TABLE 60 ROW: DIGITAL PATHOLOGY MARKET REVENUE, BY COUNTRY, 2010 – 2017($MILLION)TABLE 61 LATIN AMERICA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010– 2017 ($MILLION)TABLE 62 LATIN AMERICA: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION,2010 – 2017 ($MILLION)TABLE 63 AFRICA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 64 AFRICA: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 65 RUSSIA: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 – 2017($MILLION)TABLE 66 RUSSIA: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010 –2017 ($MILLION)TABLE 67 MIDDLE EAST: DIGITAL PATHOLOGY MARKET REVENUE, BY PRODUCTS, 2010 –2017 ($MILLION)TABLE 68 MIDDLE EAST: DIGITAL PATHOLOGY MARKET REVENUE, BY APPLICATION, 2010– 2017 ($MILLION)TABLE 69 PACIFIC COUNTRIES : DIGITAL PATHOLOGY MARKET REVENUE, BYPRODUCTS, 2010 – 2017 ($MILLION)TABLE 70 PACIFIC COUNTRIES: DIGITAL PATHOLOGY MARKET REVENUE, BYAPPLICATION, 2010 – 2017 ($MILLION)TABLE 71 MERGERS & ACQUISITIONS, 2009 – 2012
  • TABLE 72 AGREEMENTS/PARTNERSHIPS/COLLABORATIONS/ JOINT VENTURES, 2009 –2012TABLE 73 NEW PRODUCT LAUNCH, 2009 – 2012TABLE 74 OTHER DEVELOPMENTS, 2009 – 2012TABLE 75 HAMAMATSU PHOTONICS K.K.: TOTAL REVENUE AND R&D EXPENDITURE, 2009– 2011 ($MILLION)TABLE 76 HAMAMATSU PHOTONICS K.K.: TOTAL REVENUE, BY SEGMENTS, 2009 – 2011($MILLION)LIST OF FIGURESFIGURE 1 DIGITAL PATHOLOGY MARKET, BY GEOGRAPHY, 2012FIGURE 2 GLOBAL DIGITAL PATHOLOGY MARKET REVENUE, 2012 – 2017 ($MILLION)FIGURE 3 EVOLUTION OF DIGITAL PATHOLOGYFIGURE 4 GLOBAL DIGITAL PATHOLOGY MARKET, BY PRODUCT TYPEFIGURE 5 GLOBAL DIGITAL PATHOLOGY MARKET, BY APPLICATIONFIGURE 6 TITLEFIGURE 7 GLOBAL DIGITAL PATHOLOGY MARKET SHARE, BY KEY PLAYERS, 2012FIGURE 8 TYPICAL LABORATORY WORKFLOW WITH INTEGRATED DIGITAL IMAGINGFIGURE 9 KEY GROWTH STRATEGIES, 2009 – 2012Contact: sales@reportsandreports.com for more information.